ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01515969
Brief Title: Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC)

First Submitted : December 16, 2011
First Submitted that Met QC Criteria : January 23, 2012
First Posted : January 24, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : July 11, 2016
Last Update Posted : July 12, 2016 (Estimate)